TCI Wealth Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$116 2457
2023
Q1
$116 Hold
100
﹤0.01% 2388
2022
Q4
$268 Hold
100
﹤0.01% 2301
2022
Q3
$0 Hold
100
﹤0.01% 2678
2022
Q2
$0 Buy
+100
New +$524 ﹤0.01% 2591
2021
Q3
Sell
-61
Closed -$3K 2630
2021
Q2
$3K Buy
+61
New +$2.83K ﹤0.01% 1896
2021
Q1
Sell
-9
Closed -$1K 2262
2020
Q4
$1K Buy
+9
New +$757 ﹤0.01% 1494

Other funds holding CELL

TCI Wealth Advisors's CELL Position: Q2 2023 in Review

TCI Wealth Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 100 shares — an estimated $116 sold.

TCI Wealth Advisors first reported a position in CELL in Q4 2020 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • TCI Wealth Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $116.
  • TCI Wealth Advisors first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • TCI Wealth Advisors's PhenomeX Inc. Common Stock position peaked at $3K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.